Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.
E
Show more
Pharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for the treatment of diseases and disorders that affect movement; steroids
Class 5 – Pharmaceuticals & supplements
Status timeline
- 10 Mar 2020Application filedNew Application Entered
- 27 May 2020Assigned to an examining attorneyAssigned To Examiner
- 28 May 2020Approved for publicationApproved For Pub - Principal Register
- 7 Jul 2020Published for oppositionPublished For Opposition
- 1 Sep 2020Notice of allowance issued — statement of use requiredNoa Mailed - Sou Required From Applicant
- 24 Feb 2021Statement of use filedTeas Statement Of Use Received
- 12 Mar 2021Statement-of-use extension 1 grantedSou Extension 1 Granted
- 2 Apr 2021Statement of use acceptedAllowed Principal Register - Sou Accepted
- 3 Apr 2021Statement of use acceptedNotice Of Acceptance Of Statement Of Use E-Mailed
- 11 May 2021Registered on the Principal RegisterRegistered-Principal Register
All 28 events
| 2026-05-11 | Rem1 |
| 2025-11-13 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-11-13 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-11-13 | Teas Change Of Correspondence Received |
| 2023-12-20 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2023-12-20 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2023-12-20 | Teas Change Of Correspondence Received |
| 2023-12-20 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2021-05-11 | Registered-Principal Register |
| 2021-04-03 | Notice Of Acceptance Of Statement Of Use E-Mailed |
| 2021-04-02 | Allowed Principal Register - Sou Accepted |
| 2021-03-13 | Notice Of Approval Of Extension Request E-Mailed |
| 2021-03-12 | Case Assigned To Intent To Use Paralegal |
| 2021-03-12 | Sou Extension 1 Granted |
| 2021-03-12 | Statement Of Use Processing Complete |
| 2021-02-24 | Teas Statement Of Use Received |
| 2021-02-24 | Sou Teas Extension Received |
| 2021-02-24 | Sou Extension 1 Filed |
| 2021-02-24 | Use Amendment Filed |
| 2020-09-01 | Noa Mailed - Sou Required From Applicant |
| 2020-07-07 | Published For Opposition |
| 2020-07-07 | Official Gazette Publication Confirmation E-Mailed |
| 2020-06-17 | Notification Of Notice Of Publication E-Mailed |
| 2020-05-28 | Approved For Pub - Principal Register |
| 2020-05-27 | Assigned To Examiner |
| 2020-03-13 | Notice Of Design Search Code E-Mailed |
| 2020-03-12 | New Application Office Supplied Data Entered |
| 2020-03-10 | New Application Entered |
Goods & services by class
Class 5 Pharmaceuticals & supplements
Pharmaceuticals for the treatment of neurodegenerative and mitochondrial diseases and disorders; pharmaceuticals for the treatment of diseases and disorders that affect movement; steroids
First use anywhere 31 Aug 2020 · First use in commerce 31 Aug 2020
Owner details
See the official record for contact details. View official record →
Source & freshness
Source: the official United States trademark register. This record was last updated on 12 May 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.